Literature DB >> 27479639

Accuracy of MR Imaging and MR Spectroscopy for Detection and Quantification of Hepatic Steatosis in Living Liver Donors: A Meta-Analysis.

Danping Zheng1, Zhiyong Guo1, Paul M Schroder1, Zhouying Zheng1, Yao Lu1, Jincui Gu1, Xiaoshun He1.   

Abstract

Purpose To determine the accuracy of magnetic resonance (MR) imaging for detection and quantification of hepatic steatosis (HS) in living liver donor candidates. Materials and Methods A systematic search of the literature was performed to find studies on the diagnostic and quantitative accuracy of MR imaging for assessment of HS in liver donors. The Quality Assessment of Diagnostic Accuracy Studies 2 tool was used, and patient selection, index text, reference standard, and study flow and timing were assessed to evaluate the quality of each included study. Pooled sensitivity, specificity, positive and negative likelihood ratios, hierarchical summary receiver operating characteristic (ROC) curves, and the area under the curve were estimated by using hierarchical summary ROC and bivariate random-effects models. Results Eight studies involving 934 subjects were eligible for the meta-analysis. For detection of HS with MR imaging and/or MR spectroscopy in living liver donors, the pooled sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio, respectively, were 0.89 (95% confidence interval [CI]: 0.75, 0.95), 0.84 (95% CI: 0.76, 0.89), 5.53 (95% CI: 3.71, 8.25), and 0.14 (95% CI: 0.06, 0.31). The area under the curve was 0.92 (95% CI: 0.89, 0.94). For detection of substantial HS (>10% to >30% HS at liver pathologic examination, as defined in each study), these corresponding diagnostic estimates were 0.91 (95% CI: 0.82, 0.95), 0.89 (95% CI: 0.84, 0.93), 8.30 (95% CI: 5.47, 12.59), 0.10 (95% CI: 0.05, 0.21), and 0.96 (95% CI: 0.93, 0.97), respectively. Moderate heterogeneity was detected. No publication bias was detected (P = .12). Conclusion MR imaging and MR spectroscopy show high sensitivity and specificity for detection of HS, especially when HS is substantial, and may be useful for noninvasive evaluation of HS in living liver donors. © RSNA, 2016 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2016        PMID: 27479639     DOI: 10.1148/radiol.2016152571

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

Review 1.  CT and MR imaging evaluation of living liver donors.

Authors:  Federica Vernuccio; Susan A Whitney; Kadiyala Ravindra; Daniele Marin
Journal:  Abdom Radiol (NY)       Date:  2021-01

Review 2.  Contemporary strategies to assess and manage liver donor steatosis: a review.

Authors:  Christine Tien; Daphne Remulla; Yong Kwon; Juliet Emamaullee
Journal:  Curr Opin Organ Transplant       Date:  2021-10-01       Impact factor: 2.269

Review 3.  Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .

Authors:  Naga Swetha Samji; Rajiv Heda; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2020-01-05

Review 4.  Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: A PRISMA-compliant meta-analysis.

Authors:  Qing-Qin Hao; Guang-Yi Chen; Jun-Hua Zhang; Jia-He Sheng; Yun Gao
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 5.  Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis.

Authors:  Yong Ho Lee; Yongin Cho; Byung Wan Lee; Cheol Young Park; Dae Ho Lee; Bong Soo Cha; Eun Jung Rhee
Journal:  Diabetes Metab J       Date:  2019-02       Impact factor: 5.376

6.  Identification of hepatic steatosis in living liver donors by machine learning models.

Authors:  Jihye Lim; Seungbong Han; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Dong Hwan Jung; Sung-Gyu Lee; Ki-Hun Kim; Jonggi Choi
Journal:  Hepatol Commun       Date:  2022-04-04

7.  How to select the quantitative magnetic resonance technique for subjects with fatty liver: A systematic review.

Authors:  You-Wei Li; Yang Jiao; Na Chen; Qiang Gao; Yu-Kun Chen; Yuan-Fang Zhang; Qi-Ping Wen; Zong-Ming Zhang
Journal:  World J Clin Cases       Date:  2022-09-06       Impact factor: 1.534

8.  Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard.

Authors:  Sun Kyung Jeon; Ijin Joo; So Yeon Kim; Jong Keon Jang; Juil Park; Hee Sun Park; Eun Sun Lee; Jeong Min Lee
Journal:  Ultrasonography       Date:  2020-05-09

Review 9.  Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis.

Authors:  Vicneswarry Dorairaj; Siti Aishah Sulaiman; Nadiah Abu; Nor Azian Abdul Murad
Journal:  Biomedicines       Date:  2021-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.